Mononuclear cell infiltration in clear-cell renal cell carcinoma independently predicts patient survival
- PMID: 16708355
- DOI: 10.1002/cncr.21951
Mononuclear cell infiltration in clear-cell renal cell carcinoma independently predicts patient survival
Abstract
Background: The impact of mononuclear cell infiltration on renal cell carcinoma (RCC) biology has been controversial, previously reported to be associated with either a favorable or unfavorable prognosis. The objective of the current study was to evaluate associations between mononuclear cell infiltration in routinely prepared paraffin-embedded specimens with survival in patients with clear-cell RCC.
Methods: A total of 306 patients were identified treated with nephrectomy for clear-cell RCC between 1990 and 1994. A single urologic pathologist, blinded to patient outcome, reviewed the specimens and quantified the extent of mononuclear cell infiltration as absent, focal, moderate, or marked. Cancer-specific survival was estimated using the Kaplan-Meier method. Associations of mononuclear cell infiltration with death from RCC were assessed using Cox proportional hazards regression models.
Results: At last follow-up, 173 of the 306 patients studied had died, including 96 patients who died from RCC. Mononuclear cell infiltration was absent in 165 (54%), focal in 70 (23%), moderate in 53 (17%), and marked in 18 (6%). Univariately, patients with specimens that had mononuclear cell infiltration were over 2 times more likely to die from RCC compared with patients whose specimens exhibited no mononuclear cell infiltration (risk ratio, 2.63; P < .001). After adjusting for the Mayo Clinic SSIGN (stage, size, grade, and necrosis) score, patients with specimens that had mononuclear cell infiltration exhibited a significantly increased likelihood of dying from RCC compared with patients whose specimens had no mononuclear cell infiltration (risk ratio, 1.61; P = .028).
Conclusions: Mononuclear cell infiltration is associated with death from RCC even after multivariate adjustment. Routine documentation of mononuclear cell infiltration is recommended during the pathologic assessment of RCC.
Copyright 2006 American Cancer Society.
Similar articles
-
pT1 clear cell renal cell carcinoma: a study of the association between MIB-1 proliferative activity and pathologic features and cancer specific survival.Cancer. 2002 Apr 15;94(8):2180-4. doi: 10.1002/cncr.10433. Cancer. 2002. PMID: 12001115
-
External validation of the Mayo Clinic stage, size, grade, and necrosis (SSIGN) score for clear-cell renal cell carcinoma in a single European centre applying routine pathology.Eur Urol. 2010 Jan;57(1):102-9. doi: 10.1016/j.eururo.2008.11.033. Epub 2008 Nov 28. Eur Urol. 2010. PMID: 19062157
-
Histologic coagulative tumor necrosis as a prognostic indicator of renal cell carcinoma aggressiveness.Cancer. 2005 Aug 1;104(3):511-20. doi: 10.1002/cncr.21206. Cancer. 2005. PMID: 15973740
-
Long-term survival of patients with unilateral sporadic multifocal renal cell carcinoma according to histologic subtype compared with patients with solitary tumors after radical nephrectomy.Urology. 2004 Sep;64(3):462-7. doi: 10.1016/j.urology.2004.04.016. Urology. 2004. PMID: 15351571 Review.
-
Implications of B7-H1 expression in clear cell carcinoma of the kidney for prognostication and therapy.Clin Cancer Res. 2007 Jan 15;13(2 Pt 2):709s-715s. doi: 10.1158/1078-0432.CCR-06-1868. Clin Cancer Res. 2007. PMID: 17255298 Review.
Cited by
-
Colocalization of inflammatory response with B7-h1 expression in human melanocytic lesions supports an adaptive resistance mechanism of immune escape.Sci Transl Med. 2012 Mar 28;4(127):127ra37. doi: 10.1126/scitranslmed.3003689. Sci Transl Med. 2012. PMID: 22461641 Free PMC article.
-
Evaluation of programmed cell death protein 1 (PD-1) expression as a prognostic biomarker in patients with clear cell renal cell carcinoma.Oncoimmunology. 2018 Jan 10;7(4):e1413519. doi: 10.1080/2162402X.2017.1413519. eCollection 2018. Oncoimmunology. 2018. PMID: 29632730 Free PMC article.
-
Clinical significance of programmed death-1 and programmed death-ligand 1 expression in the tumor microenvironment of clear cell renal cell carcinoma.Cancer Sci. 2019 Jun;110(6):1820-1828. doi: 10.1111/cas.14019. Epub 2019 May 13. Cancer Sci. 2019. PMID: 30972888 Free PMC article.
-
Negative regulation of tumor-infiltrating NK cell in clear cell renal cell carcinoma patients through the exosomal pathway.Oncotarget. 2017 Jun 6;8(23):37783-37795. doi: 10.18632/oncotarget.16354. Oncotarget. 2017. PMID: 28384121 Free PMC article.
-
Resistance to cancer immunotherapy mediated by apoptosis of tumor-infiltrating lymphocytes.Nat Commun. 2017 Nov 10;8(1):1404. doi: 10.1038/s41467-017-00784-1. Nat Commun. 2017. PMID: 29123081 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical